HIF1A and pancreatic neoplasm: Therefore, a redox-sensitive nanoplatform co-delivering GEM and miR-159c was developed, which downregulates HIF-1α and genes responsible for glucose uptake and cancer cell metabolism, thereby significantly inhibiting orthotopic desmoplastic pancreatic cancer growth in NSG mice.